Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT01990859
Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.
Inclusion Criteria:
* Histologically or cytologically confirmed diagnosis of malignant melanoma
* Previously-treated or untreated unresectable Stage III or Stage IV melanoma
* Measurable/evaluable disease per modified World Health Organization (mWHO) criteria, within 28 days of first dose of study drug
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Exclusion Criteria:
* Active brain metastases
* Primary ocular or mucosal melanoma
* History of or current active autoimmune disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT01990859
Study Brief:
Protocol Section:
NCT01990859